VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
IDXX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
IDXXIDEXX Laboratories, Inc.
$550.96$43.5B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIDXXBalance Sheet

IDEXX Laboratories, Inc. (IDXX) Balance Sheet

30Y historyFree accessUpdated daily

Leverage remains moderate with D/E at 0.68 and total debt of $1.1B, while retained earnings surged to $7.0B from $4.7B in 2024Q1, indicating robust internal capital generation.

IDXX Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets1.51B1.34B1.4B1.5B1.1B955.65M1.06B679.64M654.17M971.99M845.58M821.63M759.4M652.71M569.54M524.23M460.59M376.34M355.89M305.66M302.26M299.25M301.59M370.59M289.12M235.58M215.83M232.4M263.3M274.2M301.7M
Cash & Short-Term Investments196.93M180.07M288.27M453.93M112.55M144.45M383.93M90.33M123.79M471.93M391.85M342.58M322.54M279.06M223.99M183.9M156.91M106.73M78.87M60.36M96.67M132.73M137.27M220.71M147.19M79.56M75.2M58.6M109.1M107M127.7M
Cash Only196.93M180.07M288.27M453.93M112.55M144.45M383.93M90.33M123.79M187.68M154.9M128.99M322.54M279.06M223.99M183.9M156.91M106.73M78.87M60.36M61.67M67.15M47.16M186.72M113.79M66.67M46.01M58.6M109.1M107M127.7M
Short-Term Investments000000000284.25M236.95M213.59M0000000035M65.58M90.12M33.99M33.4M12.89M29.2M0000
Accounts Receivable741.67M693.19M561.32M529.53M490.9M425.58M374.74M307.49M258.52M270.07M232.17M200.11M181.31M158.04M138.32M141.28M120.08M115.11M111.5M108.38M81.39M71.69M053.98M45.69M50.77M57.27M58.35M47.9M47.3M66.6M
Days Sales Outstanding57.0658.7952.5752.7953.2148.3150.5346.6342.6350.0647.7345.644.5441.8939.0442.3139.7240.7339.7442.8840.1941.01-41.3940.414856.8959.7954.6565.6490.81
Inventory391.58M377.76M381.88M380.28M367.82M269.03M209.87M195.02M173.3M164.32M158.03M188.83M160.34M133.43M140.95M133.1M127.89M110.42M115.93M98.8M96M69.37M76.42M75.33M75.09M86.19M65.94M47.5M55.4M60.2M48.4M
Days Inventory Outstanding82.3683.8691.7994.3698.574.0667.4668.3565.168.8172.196.8587.3978.4386.5884.988.9579.7685.6178.5697.4480.33103.25111.92124.61155.17140.92105.14142.2183.41171.68
Other Current Assets117.35M31.35M109.81M83.14M88.46M74.59M59.64M54.81M54.14M101.14M91.21M101.9M124.14M82.18M66.28M65.96M55.71M44.08M49.6M38.12M28.21M25.46M22.26M20.57M134.94M19.05M17.43M67.9M50.9M59.7M59M
Total Non-Current Assets1.93B2.01B1.89B1.76B1.65B1.48B1.23B1.15B883.18M741.43M685.12M653.36M624.81M577.81M534.07M506.59M436.55M432.19M409.55M396.52M257.3M191.43M212.65M151.29M127.53M137.53M119.97M127.8M127.2M102.8M72.2M
Property, Plant & Equipment856M870.61M829.25M817.68M768.09M692.77M646.34M614.45M437.27M379.1M357.42M333.03M303.59M281.21M245.18M216.78M201.72M199.95M189.65M141.85M99.63M65.7M62.63M45.22M49.45M49.22M45.66M39.55M41.5M41M36.4M
Fixed Asset Turnover5.27x4.94x4.70x4.48x4.38x4.64x4.19x3.92x5.06x5.19x4.97x4.81x4.89x4.90x5.28x5.62x5.47x5.16x5.40x6.50x7.42x9.71x8.77x10.53x8.34x7.84x8.05x9.01x7.71x6.41x7.35x
Goodwill410.95M414M405.1M365.96M361.8M359.35M243.35M239.72M214.49M199.87M178.23M178.93M184.45M180.52M174.99M172.61M149.11M148.71M138.77M236.41M104.83M88.13M000000000
Intangible Assets98.17M109.84M111.68M84.5M97.67M99.03M52.54M58.47M41.83M43.85M46.16M55.91M65.12M58.84M62.83M69.21M55.75M63.91M68.33M043.35M30.62M124.49M61.77M56.16M000000
Long-Term Investments681.26M297.09M57.72M56.19M55.5M18.6M12.06M13.66M10.89M9.95M10.98M12.16M10.77M13.07M10.32M12.09M000000000000000
Other Non-Current Assets491.12M291.08M364.17M332.98M307.01M287.02M245.98M218.44M170.22M100.97M86.63M73.33M60.89M44.16M40.74M35.9M29.33M18.61M11.64M11.61M6.24M6.57M25.52M44.3M23.8M88.32M74.31M86.02M81.7M61.8M35.8M
Total Assets3.44B3.35B3.29B3.26B2.75B2.44B2.29B1.83B1.54B1.71B1.53B1.47B1.38B1.23B1.1B1.03B897.14M808.53M765.44M702.18M559.56M490.68M514.24M521.88M416.65M373.11M335.8M360.2M390.5M377M373.9M
Asset Turnover1.34x1.28x1.18x1.12x1.23x1.32x1.18x1.31x1.44x1.15x1.16x1.09x1.07x1.12x1.17x1.18x1.23x1.28x1.34x1.31x1.32x1.30x1.07x0.91x0.99x1.03x1.09x0.99x0.82x0.70x0.72x
Asset Growth %11.51%1.74%1.03%18.68%12.7%6.22%25.22%19.2%-10.28%11.94%3.78%6.56%12.49%11.5%7.06%14.9%10.96%5.63%9.01%25.49%14.04%-4.58%-1.46%25.25%11.67%11.11%-6.78%-7.76%3.58%0.83%19.65%
Total Current Liabilities1.29B1.15B1.07B951.55M1.24B763.58M582.76M725.34M770.44M1B934.57M856.76M820.91M478.35M406.33M436.88M285.11M256.31M295.29M223.39M124.74M106.57M99.95M100.74M75.68M71.38M74.05M75.5M78.5M74.3M51.1M
Accounts Payable129.1M110.41M114.21M110.64M110.22M116.14M74.56M72.17M69.53M66.97M60.06M52.65M44.74M29.94M35.29M36.55M22.67M19.13M28.01M32.51M24.37M19.84M14.72M19.16M9.43M10.89M13.71M21.82M26.8M12.5M18.7M
Days Payables Outstanding26.2424.5127.4527.4529.5231.9723.9625.326.1228.0427.42724.3917.621.6823.3215.7713.8220.6825.8524.7422.9819.8928.4615.6419.629.3148.368.7938.0866.33
Short-Term Debt669M500.07M417.79M325M653.98M148.5M49.99M288.76M398.94M655M611M573M549M278.04M213.11M243.92M129.86M119.6M151.38M72.96M678K551K1.29M494K973K8.38M8.47M3.54M5.2M4.1M3M
Deferred Revenue (Current)143.69M35.26M33.8M37.2M37.94M40.03M42.57M41.46M41.29M29.18M27.38M25.58M31.81M21.46M20.19M15.03M13.98M12.61M11.29M10.68M8.98M7.96M10.15M8.28M13.57M13.22M00000
Other Current Liabilities158.13M201.96M174.58M174.38M142.99M182.93M167.65M127.17M109.49M102.94M91.11M77.03M75.23M62.47M53.41M51.37M00001.78M2.19M2.79M2.25M0051.86M48.28M42.5M57.7M29.4M
Current Ratio1.17x1.17x1.31x1.57x0.89x1.25x1.82x0.94x0.85x0.97x0.90x0.96x0.93x1.36x1.40x1.20x1.62x1.47x1.21x1.37x2.42x2.81x3.02x3.68x3.82x3.30x2.91x3.08x3.35x3.69x5.90x
Quick Ratio0.87x0.84x0.95x1.17x0.59x0.90x1.46x0.67x0.62x0.80x0.74x0.74x0.73x1.09x1.05x0.90x1.17x1.04x0.81x0.93x1.65x2.16x2.25x2.93x2.83x2.09x2.02x2.45x2.65x2.88x4.96x
Cash Conversion Cycle113.17118.14116.9119.7122.290.494.0389.6981.6190.8392.43115.45107.54102.72103.94103.9112.9106.66104.6795.59112.8998.36-124.84149.37183.57168.5116.64128.06210.97196.16
Total Non-Current Liabilities542.1M596.56M630.21M823.85M902.23M983.63M1.08B929.31M776.14M762.69M704.35M702.23M445.72M233.95M61.01M54.34M37.75M37.64M31.95M40.46M24.96M14.8M16.63M7.85M6.2M00400K4.2M1.4M100K
Long-Term Debt299.87M475.99M449.79M622.88M694.39M775.21M858.49M698.91M601.35M606.08M593.11M597.09M350M150.36M1.39M2.5M3.42M4.28M5.09M5.73M6.45M0519K786K000300K4.2M00
Capital Lease Obligations406.89M101.15M97.84M99.67M101.24M87.38M77.04M67.47M00000000000000000000000
Deferred Tax Liabilities132.82M31.86M11.31M7.24M8.15M8.94M11.71M33.02M29.27M25.35M39.29M49.39M41.69M33.95M23.03M23.29M18.66M18.28M11.93M14.7M7.15M6.03M8.45M236K0000000
Other Non-Current Liabilities56.5M-44.62M44.34M65.53M67.59M70.94M85.6M81.16M84.83M95.72M38.94M28.7M32.36M31.21M23.9M17.73M11.04M11.27M11.14M13.83M4.52M968K1.01M1.05M000-259K00100K
Total Liabilities1.83B1.75B1.7B1.78B2.14B1.75B1.66B1.65B1.55B1.77B1.64B1.56B1.27B712.3M467.35M491.22M322.86M293.95M327.24M263.86M149.7M121.37M116.58M108.58M75.68M71.38M74.05M75.9M82.7M74.3M51.2M
Total Debt1.1B1.08B986.95M1.07B1.47B1.03B1B1.07B1B1.26B1.2B1.17B899M428.39M214.5M246.42M133.28M123.88M156.48M78.68M7.13M551K1.81M1.28M1.02M8.38M8.47M3.84M9.4M4.1M3M
Net Debt899.15M897.14M698.68M613.42M1.36B886.55M619.32M980.1M876.49M1.07B1.05B1.04B576.46M149.34M-9.48M62.52M-23.64M17.16M77.61M18.32M-54.54M-66.6M-45.35M-95.66M-112.77M-58.29M-37.53M-54.73M-99.7M-102.9M-124.7M
Debt / Equity0.68x0.67x0.62x0.72x2.41x1.49x1.59x6.02x----7.65x0.83x0.34x0.46x0.23x0.24x0.36x0.18x0.02x0.00x0.00x0.00x0.00x0.03x0.03x0.01x0.03x0.01x0.01x
Debt / EBITDA0.68x0.73x0.78x0.88x1.45x0.99x1.27x1.67x1.74x2.54x2.81x3.17x2.82x1.33x0.68x0.87x0.53x0.55x0.71x0.44x0.05x0.00x0.01x0.01x0.01x0.11x0.12x0.06x0.21x0.41x0.05x
Net Debt / EBITDA0.56x0.61x0.56x0.51x1.34x0.86x0.78x1.53x1.53x2.16x2.45x2.82x1.81x0.46x-0.03x0.22x-0.09x0.08x0.35x0.10x-0.35x-0.48x-0.36x-0.96x-1.31x-0.74x-0.52x-0.86x-2.22x-10.29x-2.17x
Interest Coverage37.44x35.61x36.57x26.52x22.58x31.28x20.98x17.82x14.17x11.24x11.04x10.34x16.98x49.88x68.73x131.99x116.75x123.40x38.09x------------
Total Equity1.61B1.61B1.6B1.48B608.74M689.99M632.79M177.82M-9.23M-53.84M-108.21M-84M117.59M518.21M636.26M539.59M574.28M514.58M438.19M438.32M409.86M369.31M397.66M413.29M340.97M301.73M261.75M284.3M307.8M302.7M322.7M
Equity Growth %15.12%0.63%7.46%143.87%-11.78%9.04%255.85%2025.97%82.85%50.24%-28.83%-171.43%-77.31%-18.55%17.91%-6.04%11.6%17.43%-0.03%6.94%10.98%-7.13%-3.78%21.21%13.01%15.28%-7.93%-7.63%1.68%-6.2%15.62%
Book Value per Share19.9919.9019.1617.687.207.977.302.03-0.10-0.60-1.19-0.901.164.805.674.634.824.243.523.403.112.712.782.882.432.181.811.792.032.012.05
Total Shareholders' Equity1.61B1.61B1.6B1.48B608.74M689.99M632.09M177.47M-9.51M-54.11M-108.35M-84.13M117.52M518.19M636.22M539.58M574.24M514.57M438.19M438.32M409.86M369.01M397.66M413.29M340.97M301.73M261.75M284.3M307.8M302.7M322.7M
Common Stock10.87M10.84M10.78M10.75M10.72M10.69M10.65M10.57M10.51M10.43M10.33M10.26M10.2M10.12M10.02M9.92M9.8M9.63M9.54M9.45M4.66M4.59M4.52M4.44M4.23M4.13M4.03M4M000
Retained Earnings7.01B6.39B5.33B4.44B3.6B2.92B2.18B1.6B1.17B803.54M540.4M318.36M1.68B1.49B1.31B1.13B965.54M824.26M702.03M585.86M490.61M396.94M318.68M240.35M183.26M137.87M100.25M63.6M31M46.3M67.4M
Treasury Stock-7.26B-6.56B-5.33B-4.47B-4.39B-3.57B-2.8B-2.6B-2.29B-1.91B-1.63B-1.32B-2.45B-1.83B-1.46B-1.32B-1.06B-914.76M-830.39M-696.67M-577.83M-472.1M-348.33M-219.45M-178.36M-147.47M-134.48M-64.2M000
Accumulated OCI-63.54M-68.84M-93.64M-71.21M-77.8M-53.48M-53.62M-46.18M-41.79M-36.47M-43.05M-42.27M-8.07M13.62M15.95M15.44M13.47M10.34M5.67M24.91M12.42M2.18M11.97M4.7M-2.51M-6.69M-4.96M-3.5M-41M-30.4M-22.9M
Minority Interest000000707K352K280K264K139K130K73K28K34K14K46K10K000300K000000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Corporate consolidation pricing pressure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Strengthens Amidst Growth

IDEXX's total assets have held steady near $3.4B while equity grew to $1.6B by 2026Q2, per reported figures, indicating a stable yet improving capital base.

The balance sheet appears to be strengthening as retained earnings climbed from $4.7B in 2024Q1 to $7.0B in 2026Q2, reflecting robust profitability. Total liabilities have remained roughly flat around $1.8B, suggesting that asset growth is being funded internally rather than through additional debt. This trend implies a self-sustaining business model with improving financial flexibility.

Moderate Leverage with Stable Debt Levels

Total debt has hovered near $1.1B over the past year, with D/E fluctuating between 0.62 and 0.85, as per quarterly data, indicating manageable leverage.

The debt-to-equity ratio peaked at 0.85 in 2025Q2 but has since declined to 0.68 in 2026Q2, suggesting a slight deleveraging trend. Debt levels appear stable and are likely strategic, supporting growth initiatives rather than covering operational shortfalls. Given the company's strong cash flow generation, refinancing risk appears low, but investors should monitor any future increases in leverage.

Asset Mix Reflects Asset-Light Model

PP&E net of $856M represents about 25% of total assets, while goodwill of $411M is stable, per reported figures, indicating a balanced asset base.

The relatively low PP&E intensity suggests an asset-light model, consistent with a diagnostics company that relies on consumables and services rather than heavy manufacturing. Goodwill has remained stable around $410M, implying no major acquisitions or impairment concerns. The asset mix supports high returns on invested capital, as the business generates significant revenue from a modest fixed asset base.

Equity Growth Driven by Retained Earnings

Retained earnings surged to $7.0B in 2026Q2 from $4.7B in 2024Q1, per financial statements, while equity grew to $1.6B, indicating strong internal capital generation.

The growth in retained earnings far outpaces the increase in total equity, which suggests that share repurchases are offsetting some of the earnings retention. Despite aggressive buybacks, equity has remained stable, indicating that the company is returning capital to shareholders while still building its equity base. This balance between reinvestment and shareholder returns appears sustainable.

Liquidity Adequate but Cash Buffer Thins

Current ratio improved to 1.17 in 2026Q2 from 1.11 a year earlier, but cash fell to $196.9M from $401.6M in 2024Q2, per reported data.

The current ratio remains above 1.0, indicating sufficient short-term assets to cover liabilities, but the cash balance has declined significantly over the past two years. This decline is likely due to share repurchases and debt repayments, as operating cash flow remains robust. The liquidity position appears adequate for near-term obligations, but the shrinking cash buffer warrants monitoring if cash generation slows.

Hidden Risk in Customer Concentration

The shift toward large corporate veterinary groups could erode pricing power, as suggested by the company's reliance on fragmented independent clinics.

While IDEXX's balance sheet appears healthy, the growing consolidation of veterinary practices into large corporate entities may pose a long-term threat. These large buyers could demand volume discounts, pressuring margins and potentially affecting the stability of deferred revenue and cash flows. This risk is not immediately visible in the balance sheet but could impact future asset quality and profitability.

IDXX — Frequently Asked Questions

Quick answers to the most common questions about buying IDXX stock.

What are the total assets of IDEXX Laboratories, Inc. (IDXX)?

As of 2025, IDEXX Laboratories, Inc. (IDXX) had total assets of $3.35B including $1.34B in current assets.

How much debt does IDEXX Laboratories, Inc. (IDXX) have?

IDEXX Laboratories, Inc. (IDXX) carries total debt of $1.08B, offset by $180.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of IDEXX Laboratories, Inc.?

IDEXX Laboratories, Inc. (IDXX) has total shareholders' equity (book value) of $1.61B ($19.90 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is IDEXX Laboratories, Inc.'s current ratio and liquidity?

IDEXX Laboratories, Inc. (IDXX) reported a current ratio of 1.17x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.